Steven E Nissen

发表

Coronary imaging: angiography shows the stenosis, but IVUS, CT, and MRI show the plaque.

Richard D. White, Paul Schoenhagen, Richard D White, 2003, Cleveland Clinic journal of medicine.

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Raimund Erbel, Jean-Claude Tardif, Paul Schoenhagen, 2006, JAMA.

Automated three-dimensional assessment of coronary artery anatomy with intravascular ultrasound scanning.

Azita Tajaddini, Paul Schoenhagen, Jon D Klingensmith, 2003, American heart journal.

Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis.

S. Nissen, Steven E Nissen, 2002, The American journal of cardiology.

Limitations of computed tomography coronary angiography.

S. Nissen, Steven E Nissen, 2008, Journal of the American College of Cardiology.

The new era of medical imaging.

S. Nissen, Steven E Nissen, 2006, The New England journal of medicine.

Effect of ACAT inhibition on the progression of coronary atherosclerosis.

Carl J Pepine, Paul Schoenhagen, E. Michelson, 2006, The New England journal of medicine.

ADAPT: The Wrong Way to Stop a Clinical Trial

S. Nissen, Steven E Nissen, 2006, PLoS clinical trials.

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

Craig Wilson, Christopher P Cannon, Faiez Zannad, 2013, The New England journal of medicine.

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

S. Nissen, K. Wolski, Steven E Nissen, 2007, The New England journal of medicine.

Effect of torcetrapib on the progression of coronary atherosclerosis.

Jean-Claude Tardif, E. Tuzcu, J. Tardif, 2007, The New England journal of medicine.

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

Paul Schoenhagen, John Tsai, Tim Crowe, 2005, The New England journal of medicine.

Effect of two intensive statin regimens on progression of coronary disease.

Peter Libby, P. Libby, R. Erbel, 2011, The New England journal of medicine.

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Ming-Dauh Wang, M. Shao, J. Kastelein, 2011, JAMA.

Noninvasive imaging of coronary arteries: current and future role of multi-detector row CT.

Richard D. White, Paul Schoenhagen, Richard D White, 2004, Radiology.

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Paul Schoenhagen, Tim Crowe, C. Grines, 2004, JAMA.

Coronary artery calcification and changes in atheroma burden in response to established medical therapies.

Paul Schoenhagen, Stanley L Hazen, E. Tuzcu, 2007, Journal of the American College of Cardiology.

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Paul Schoenhagen, Taro Tsunoda, Tim Crowe, 2003, JAMA.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

John B Buse, B. Zinman, S. Pocock, 2016, The New England journal of medicine.

Exploring coronary atherosclerosis with intravascular imaging.

Rishi Puri, E. Tuzcu, S. Nissen, 2013, International journal of cardiology.

Coronary atherosclerosis can regress with very intensive statin therapy.

E. Tuzcu, S. Nissen, S. Nicholls, 2006, Cleveland Clinic journal of medicine.

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Eric J Topol, Peter Libby, P. Libby, 2004, JAMA.

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Paul Schoenhagen, Milind Y Desai, Stanley L Hazen, 2007, JAMA.

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

A. Lincoff, S. Nissen, S. Nicholls, 2007, JAMA.

Intravascular ultrasound in cardiovascular medicine.

Paul Schoenhagen, E. Tuzcu, P. Schoenhagen, 2006, Circulation.

The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis.

Paul Schoenhagen, E. Tuzcu, P. Schoenhagen, 2010, Archives of internal medicine.

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.

Allen J. Taylor, C. Ballantyne, J. Kastelein, 2011, Journal of the American College of Cardiology.

Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial

Paul Schoenhagen, Carolyn Apperson-Hansen, Tim Crowe, 2006, Circulation.

Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial.

Volkan Ozduran, Paul Schoenhagen, E. Tuzcu, 2006, European heart journal.

Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.

Paul Schoenhagen, M. Shao, E. Tuzcu, 2010, Journal of the American College of Cardiology.

Impact of statins on serial coronary calcification during atheroma progression and regression.

Yu Kataoka, Rishi Puri, M. Shao, 2015, Journal of the American College of Cardiology.

Spotty calcification and plaque vulnerability in vivo: frequency-domain optical coherence tomography analysis.

Yu Kataoka, Bhanu Duggal, Rishi Puri, 2014, Cardiovascular diagnosis and therapy.